Tag archief: English Only

Ambarella Introduces CV5 High Performance AI Vision Processor for Single 8K and Multi-Imager AI Cameras

Ambarella’s new 5 nm CV5 AI vision CVflow® processor sets a new standard for power efficiency with 8K video recording in under 2 watts SANTA...

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

● Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients ● Scientists from both companies will...

ADVA achieves record profitability with preliminary Q4 2020 financial results

Quarterly revenues EUR 140.6 million, annual EUR 565.0 million at the lower end of guidance Quarterly pro forma operating income EUR 14.4 million (10.2% of...

LG Chem to Contribute to Global Polio Eradication with Eupolio™, the First Sabin Inactivated Polio Vaccine to Receive WHO Prequalification

SEOUL, South Korea–(BUSINESS WIRE)– LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received World Health Organization (WHO) prequalification effective December 21st, 2020,...

H.I.G. Capital Invests in Makios Logistics

LONDON–(BUSINESS WIRE)– H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with $43 billion of equity capital under management, announced today that one of...

EXFO Partners With Openreach for Ground-Breaking Full Fibre Initiative

Openreach to deploy permanent Full Fibre monitoring technology to help deliver ultrafast and ultra-reliable broadband to millions of UK homes and businesses. LONDON–(BUSINESS WIRE)– EXFO...

Inotrem’s COVID-19 Phase IIa Clinical Trial Declared “National Priority Research” by the French Government’s Clinical Trial Council

PARIS–(BUSINESS WIRE)– Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announces today that its Phase IIa study of...

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

Marketing Authorisation granted by European Commission for ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) to be used with Janssen’s Rekambys (rilpivirine injection) and Edurant (rilpivirine...

Elliott Statement on ARYZTA

LONDON–(BUSINESS WIRE)– Elliott Advisors (UK) Limited (“Elliott”) notes ARYZTA AG’s (the “Company”) announcement of 18 December, and the Board’s decision to reject Elliott’s offer for...

Arch Insurance Receives Approval for Part VII Transfer

The transfer relates to insurance business conducted in any state within the EEA LONDON–(BUSINESS WIRE)– Arch Insurance (UK) Limited has today announced that it has...

IFF Achieves EcoVadis Platinum Rating for Corporate Social Responsibility Leadership

Result Places IFF Among Top 1% of Companies Assessed NEW YORK–(BUSINESS WIRE)– IFF (NYSE:IFF) (TASE: IFF), a leading innovator of taste, scent, nutrition & ingredients,...

VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)

As in ANCA vasculitis, avacopan demonstrated statistically significant improvement in renal function as measured by eGFR compared to placebo over 26 weeks of blinded treatment...

H.I.G. Capital Acquires Office Building in Bloomsbury

H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with $42 billion of equity capital under management, announced today that one of its affiliates...

Takeda Furthers Innovation-Focused Strategy in China with Sale of Select Non-Core Assets to Hasten for $322 million USD

− Takeda continues to execute on global strategy focused on life-transforming treatments for patients living with complex and rare diseases − Fast tracks innovative medicines...

Inotrem announces Data Monitoring Committee (DMC) recommends continuation of Phase IIa study of nangibotide for the treatment of severe forms of COVID-19

PARIS–(BUSINESS WIRE)– Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announces today that an independent Data Monitoring Committee...